Judy Gilford
on October 24, 2026
2 views
Researchers have explored a promising approach to treating basal cell carcinoma, the most common form of skin cancer, using a topical combination of 30% vitamin C and dimethyl sulfoxide (DMSO). In a comparative clinical trial published in Biomedicine & Pharmacotherapy, scientists investigated whether this formulation could effectively target low-risk cancerous skin lesions without invasive procedures. DMSO acts as a penetration-enhancing solvent, potentially allowing vitamin C to reach deeper layers of affected tissue. After eight weeks of twice-daily application, researchers reported complete clearance in approximately 86.7% of treated lesions, suggesting encouraging therapeutic potential. The treatment was also associated with relatively few reported adverse effects, raising interest in its possible advantages over certain conventional topical treatments. These findings have attracted attention because basal cell carcinoma affects millions of people worldwide, creating demand for accessible and less invasive treatment options. Although additional large-scale research is necessary to establish long-term effectiveness, recurrence rates, and safety, the vitamin C and DMSO combination represents an interesting direction in experimental skin cancer treatment research.
Dimension: 1638 x 2048
File Size: 285.16 Kb
Like (2)
Loading...
2
Nancyjg
I saw that. Topical Iver also has shown promise.
October 24, 2026
Tim_Toolmann
Please don't share this with Liberals, and that it should absolutely not be injested 👌
October 24, 2026